CMIRX Mutual Fund

CMIRX Mutual Fund

NAV$10.80
See how much of CMIRX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
$3M
Expense Ratio
1.25%
Dividend Yield (Current)
0.93%
Holdings
30
Inception Date
Dec 17, 2021
Fund Family
Conestoga Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+10.29%
1 Year+21.31%
3 Year+10.71%

Asset Allocation

Stocks: 98.39%
Cash: 1.61%
See how much of CMIRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
MMMBMamamancini's Holdings Inc5.68%
TWSTTwist Bioscience Corp Common Stock Usd 0.000015.47%
PLMRPalomar Holdings Inc4.99%
VCELVericel Corp4.57%
TRNSTranscat Inc4.46%
Top 10 Concentration: 45.38%Report Date: Mar 31, 2026
Download all 30 holdings for CMIRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.93%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

CMIRX Mutual Fund Overview

CMIRX Mutual Fund (Conestoga Discovery Fund Class Institutional) is managed by Conestoga Funds with $3.3M in net assets. CMIRX expense ratio is 1.25%, holding 30 positions across sectors including Industrials, Health Care, Information Technology. Inception date: 2021-12-17.

CMIRX performance shows a YTD return of 10.29%. The 1-year return is 21.31%. CMIRX dividend yield stands at 0.93%, paid annually.

CMIRX top holdings include Mamamancini's Holdings Inc (5.7%), Twist Bioscience Corp Common Stock Usd 0.00001 (5.5%), Palomar Holdings Inc (5.0%), Vericel Corp (4.6%), Transcat Inc (4.5%). Go to all CMIRX holdings, CMIRX sectors, or CMIRX dividends.

CMIRX can be compared against other funds. Use CMIRX overlap to find shared positions, or CMIRX vs another fund for a side-by-side view. CMIRX alternatives are available via the screener, along with tax-loss harvesting opportunities.